Molecular Partners AG
MOLN
$4.45
$0.133.01%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -91.14% | -67.23% | -27.77% | -27.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -91.14% | -67.23% | -27.77% | -27.94% |
| Cost of Revenue | -16.26% | -13.35% | -8.28% | 1.26% | 9.72% |
| Gross Profit | 4.83% | -0.96% | -1.09% | -6.24% | -18.15% |
| SG&A Expenses | -7.07% | -3.96% | -4.88% | -6.06% | -4.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.72% | -10.78% | -7.32% | -0.92% | 5.46% |
| Operating Income | 5.51% | 0.56% | 0.78% | -2.16% | -10.32% |
| Income Before Tax | -0.05% | -15.74% | -1.61% | 11.10% | -9.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.05% | -15.74% | -1.61% | 11.09% | -9.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.05% | -15.74% | -1.61% | 11.09% | -9.44% |
| EBIT | 5.51% | 0.56% | 0.78% | -2.16% | -10.32% |
| EBITDA | 5.58% | 0.49% | 0.71% | -2.16% | -10.60% |
| EPS Basic | 11.10% | -5.80% | 4.15% | 13.84% | -8.32% |
| Normalized Basic EPS | 15.23% | -1.50% | 4.16% | 13.85% | -8.30% |
| EPS Diluted | 11.00% | -5.91% | 4.04% | 13.74% | -8.32% |
| Normalized Diluted EPS | 15.23% | -1.50% | 4.16% | 13.85% | -8.30% |
| Average Basic Shares Outstanding | 12.45% | 9.57% | 6.65% | 3.85% | 1.02% |
| Average Diluted Shares Outstanding | 12.45% | 9.57% | 6.65% | 3.85% | 1.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |